Financhill
Sell
39

UNP Quote, Financials, Valuation and Earnings

Last price:
$234.14
Seasonality move :
3.64%
Day range:
$232.51 - $235.22
52-week range:
$204.66 - $256.84
Dividend yield:
2.32%
P/E ratio:
19.91x
P/S ratio:
5.72x
P/B ratio:
8.04x
Volume:
2.1M
Avg. volume:
3.2M
1-year change:
3.66%
Market cap:
$139.2B
Revenue:
$24.3B
EPS (TTM):
$11.78
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $19.5B $21.8B $24.9B $24.1B $24.3B
Revenue Growth (YoY) -10.02% 11.63% 14.09% -3.04% 0.54%
 
Cost of Revenues $10.4B $11.3B $13.7B $13.6B $13.2B
Gross Profit $9.2B $10.5B $11.2B $10.5B $11B
Gross Profit Margin 46.99% 48.22% 44.86% 43.5% 45.37%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.3B $1.2B $1.3B $1.4B $1.3B
Other Inc / (Exp) $275M $293M $403M $439M $274M
Operating Expenses $1.3B $1.2B $1.3B $1.4B $1.3B
Operating Income $7.8B $9.3B $9.9B $9B $9.7B
 
Net Interest Expenses $1.1B $1.2B $1.3B $1.3B $1.3B
EBT. Incl. Unusual Items $7B $8.5B $9.1B $8.2B $8.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6B $2B $2.1B $1.9B $2B
Net Income to Company $5.3B $6.5B $7B $6.4B $6.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.3B $6.5B $7B $6.4B $6.7B
 
Basic EPS (Cont. Ops) $7.90 $9.98 $11.24 $10.47 $11.10
Diluted EPS (Cont. Ops) $7.88 $9.95 $11.21 $10.45 $11.09
Weighted Average Basic Share $677.3M $653.8M $622.7M $609.2M $607.6M
Weighted Average Diluted Share $679.1M $655.4M $624M $610.2M $608.6M
 
EBITDA $10B $11.5B $12.2B $11.4B $12.1B
EBIT $7.8B $9.3B $9.9B $9B $9.7B
 
Revenue (Reported) $19.5B $21.8B $24.9B $24.1B $24.3B
Operating Income (Reported) $7.8B $9.3B $9.9B $9B $9.7B
Operating Income (Adjusted) $7.8B $9.3B $9.9B $9B $9.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $5.6B $6.6B $5.9B $6.1B $6.2B
Revenue Growth (YoY) 13.15% 17.97% -9.52% 2.53% 2.51%
 
Cost of Revenues $2.9B $3.6B $3.4B $3.3B $3.3B
Gross Profit $2.7B $3B $2.5B $2.8B $2.9B
Gross Profit Margin 48.55% 44.96% 42.86% 45.36% 46.37%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $270M $319M $378M $354M $352M
Other Inc / (Exp) $38M $124M $106M $87M --
Operating Expenses $270M $319M $378M $354M $352M
Operating Income $2.4B $2.6B $2.2B $2.4B $2.5B
 
Net Interest Expenses $290M $315M $334M $314M $327M
EBT. Incl. Unusual Items $2.2B $2.4B $1.9B $2.2B $2.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $507M $547M $421M $518M $530M
Net Income to Company $1.7B $1.9B $1.5B $1.7B $1.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.7B $1.9B $1.5B $1.7B $1.8B
 
Basic EPS (Cont. Ops) $2.58 $3.05 $2.51 $2.75 $3.02
Diluted EPS (Cont. Ops) $2.57 $3.05 $2.51 $2.75 $3.01
Weighted Average Basic Share $648.7M $620.4M $608.7M $607.6M $592.4M
Weighted Average Diluted Share $650.3M $621.5M $609.8M $608.6M $593.2M
 
EBITDA $3B $3.2B $2.8B $3B $3.2B
EBIT $2.4B $2.6B $2.2B $2.4B $2.5B
 
Revenue (Reported) $5.6B $6.6B $5.9B $6.1B $6.2B
Operating Income (Reported) $2.4B $2.6B $2.2B $2.4B $2.5B
Operating Income (Adjusted) $2.4B $2.6B $2.2B $2.4B $2.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $21.2B $24.4B $24.1B $24.3B $24.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.9B $13.2B $13.7B $13.3B $13.3B
Gross Profit $10.3B $11.2B $10.4B $11B $11.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.4B $1.3B $1.4B $1.4B $1.3B
Other Inc / (Exp) $279M $413M $452M $304M --
Operating Expenses $1.4B $1.3B $1.4B $1.4B $1.3B
Operating Income $8.9B $9.9B $9B $9.6B $9.9B
 
Net Interest Expenses $1.1B $1.2B $1.3B $1.3B $1.3B
EBT. Incl. Unusual Items $8B $9.1B $8.2B $8.7B $9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.9B $2.1B $1.9B $2.1B $2B
Net Income to Company $6.2B $7.1B $6.4B $6.6B $7.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.2B $7.1B $6.4B $6.6B $7.1B
 
Basic EPS (Cont. Ops) $9.37 $11.24 $10.43 $10.90 $11.80
Diluted EPS (Cont. Ops) $9.35 $11.21 $10.41 $10.88 $11.78
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $11.1B $12.2B $11.4B $12B $12.4B
EBIT $8.9B $9.9B $9B $9.6B $9.9B
 
Revenue (Reported) $21.2B $24.4B $24.1B $24.3B $24.5B
Operating Income (Reported) $8.9B $9.9B $9B $9.6B $9.9B
Operating Income (Adjusted) $8.9B $9.9B $9B $9.6B $9.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $16.1B $18.7B $18B $18.1B $18.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.3B $10.2B $10.2B $9.9B $10B
Gross Profit $7.8B $8.5B $7.7B $8.2B $8.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $874M $987M $1.1B $1B $1B
Other Inc / (Exp) $214M $334M $383M $248M $185M
Operating Expenses $874M $987M $1.1B $1B $1B
Operating Income $6.9B $7.5B $6.6B $7.2B $7.4B
 
Net Interest Expenses $862M $938M $1B $957M $984M
EBT. Incl. Unusual Items $6.3B $6.9B $6B $6.5B $6.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4B $1.5B $1.3B $1.5B $1.5B
Net Income to Company $4.8B $5.4B $4.7B $5B $5.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.8B $5.4B $4.7B $5B $5.3B
 
Basic EPS (Cont. Ops) $7.32 $8.57 $7.76 $8.19 $8.88
Diluted EPS (Cont. Ops) $7.30 $8.55 $7.75 $8.18 $8.87
Weighted Average Basic Share $2B $1.9B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $2B $1.9B $1.8B $1.8B $1.8B
 
EBITDA $8.6B $9.2B $8.4B $9B $9.3B
EBIT $6.9B $7.5B $6.6B $7.2B $7.4B
 
Revenue (Reported) $16.1B $18.7B $18B $18.1B $18.4B
Operating Income (Reported) $6.9B $7.5B $6.6B $7.2B $7.4B
Operating Income (Adjusted) $6.9B $7.5B $6.6B $7.2B $7.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.9B $1B $1B $1.1B $1B
Short Term Investments $60M $46M $46M $16M $20M
Accounts Receivable, Net $1.5B $1.7B $1.9B $2.1B $1.9B
Inventory $638M $621M $741M $743M $769M
Prepaid Expenses -- -- -- -- --
Other Current Assets $212M $202M $301M $261M $322M
Total Current Assets $4.2B $3.6B $4B $4.1B $4B
 
Property Plant And Equipment $55.8B $56.7B $57.7B $59B $59.6B
Long-Term Investments $2.2B $2.3B $2.4B $2.7B $2.7B
Goodwill -- -- -- -- --
Other Intangibles $679M $686M $729M $814M $791M
Other Long-Term Assets $249M $1.1B $1.4B $1.3B $1.4B
Total Assets $63.5B $64.5B $66.3B $68B $68.5B
 
Accounts Payable $612M $752M $784M $856M $847M
Accrued Expenses $843M $517M $621M $696M $691M
Current Portion Of Long-Term Debt $960M $2.2B $1.7B $1.4B $1.4B
Current Portion Of Capital Lease Obligations $430M $330M $331M $355M $346M
Other Current Liabilities $592M $404M $431M $460M $613M
Total Current Liabilities $4.2B $5.7B $5.5B $5.1B $5.3B
 
Long-Term Debt $26.9B $29B $32.9B $32.4B $30.7B
Capital Leases -- -- -- -- --
Total Liabilities $46.5B $50.3B $54.2B $53.2B $51.6B
 
Common Stock $2.8B $2.8B $2.8B $2.8B $2.8B
Other Common Equity Adj -$1.6B -$914M -$582M -$614M -$723M
Common Equity $17B $14.2B $12.2B $14.8B $16.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $17B $14.2B $12.2B $14.8B $16.9B
 
Total Liabilities and Equity $63.5B $64.5B $66.3B $68B $68.5B
Cash and Short Terms $1.9B $1B $1B $1.1B $1B
Total Debt $28B $31.2B $34.6B $33.8B $32.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $1.3B $1.3B $788M $969M $845M
Short Term Investments $46M $46M $16M $20M --
Accounts Receivable, Net $1.7B $2.1B $1.9B $2B $1.9B
Inventory $664M $794M $770M $775M $782M
Prepaid Expenses -- -- -- -- --
Other Current Assets $227M $246M $343M $371M --
Total Current Assets $3.8B $4.4B $3.8B $4.1B $3.9B
 
Property Plant And Equipment $56B $57.4B $58.7B $59.4B $60.5B
Long-Term Investments $2.3B $2.3B $2.7B $2.7B $2.9B
Goodwill -- -- -- -- --
Other Intangibles $671M $719M $735M $807M --
Other Long-Term Assets $285M $1.2B $1.5B $1.4B --
Total Assets $62.4B $65.3B $66.5B $67.6B $68.6B
 
Accounts Payable $683M $916M $936M $830M $853M
Accrued Expenses $758M $457M $541M $608M --
Current Portion Of Long-Term Debt $1.8B $1.7B $1.7B $1.7B --
Current Portion Of Capital Lease Obligations $306M $326M $362M $349M --
Other Current Liabilities $689M $483M $394M $452M --
Total Current Liabilities $5.1B $5.7B $5.3B $5.4B $5.2B
 
Long-Term Debt $28.8B $33B $32.4B $30.7B $31.1B
Capital Leases -- -- -- -- --
Total Liabilities $48.4B $53.6B $52.5B $51B $51.3B
 
Common Stock $2.8B $2.8B $2.8B $2.8B $2.8B
Other Common Equity Adj -$1.5B -$832M -$497M -$692M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $13.9B $11.7B $14B $16.6B $17.3B
 
Total Liabilities and Equity $62.4B $65.3B $66.5B $67.6B $68.6B
Cash and Short Terms $1.3B $1.3B $788M $969M $845M
Total Debt $30.7B $34.7B $34.1B $32.3B $32.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $5.3B $6.5B $7B $6.4B $6.7B
Depreciation & Amoritzation $2.2B $2.2B $2.2B $2.3B $2.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $90M -$217M -$169M -$177M $179M
Change in Inventories $113M $17M -$120M -$2M -$26M
Cash From Operations $8.5B $9B $9.4B $8.4B $9.3B
 
Capital Expenditures $2.9B $2.9B $3.6B $3.6B $3.5B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.7B -$2.7B -$3.5B -$3.7B -$3.3B
 
Dividends Paid (Ex Special Dividend) $2.6B $2.8B $3.2B $3.2B $3.2B
Special Dividend Paid
Long-Term Debt Issued $4B $4.2B $6.1B $1.6B $800M
Long-Term Debt Repaid -$2.4B -$1.3B -$2.3B -$2.2B -$2.2B
Repurchase of Common Stock $3.7B $7.3B $6.3B $705M $1.5B
Other Financing Activities -$67M $31M -$235M -$156M $77M
Cash From Financing -$4.9B -$7.2B -$5.9B -$4.6B -$6.1B
 
Beginning Cash (CF) $1.8B $979M $983M $1.1B $1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $962M -$835M $4M $87M -$46M
Ending Cash (CF) $2.8B $144M $987M $1.2B $974M
 
Levered Free Cash Flow $5.6B $6.1B $5.7B $4.8B $5.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.7B $1.9B $1.5B $1.7B $1.8B
Depreciation & Amoritzation $553M $563M $580M $602M $618M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$13M -- -$108M $82M -$6M
Change in Inventories $24M -$4M -$28M $32M -$8M
Cash From Operations $2.3B $2.9B $2.1B $2.7B $2.5B
 
Capital Expenditures $755M $1B $975M $831M $950M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$721M -$1B -$976M -$834M -$952M
 
Dividends Paid (Ex Special Dividend) $695M $806M $792M $815M $819M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1B $2B -- -- --
Long-Term Debt Repaid -$431M -$521M -$515M -$413M --
Repurchase of Common Stock $1.4B $2B -- $731M --
Other Financing Activities -$2M -$204M $114M $249M --
Cash From Financing -$1.5B -$1.4B -$1.2B -$2B -$1.8B
 
Beginning Cash (CF) $1.2B $1.3B $772M $949M $825M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $79M $470M -$62M -$190M -$253M
Ending Cash (CF) $1.3B $1.8B $710M $759M $572M
 
Levered Free Cash Flow $1.5B $1.9B $1.2B $1.8B $1.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $6.2B $7.1B $6.4B $6.6B $7.1B
Depreciation & Amoritzation $2.2B $2.2B $2.3B $2.4B $2.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$114M -$373M $123M -$102M $115M
Change in Inventories -$15M -$130M $24M -$5M -$7M
Cash From Operations $9.1B $9.6B $8.3B $9.1B $9.7B
 
Capital Expenditures $2.6B $3.7B $3.5B $3.6B $3.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.4B -$3.5B -$3.6B -$3.4B -$3.7B
 
Dividends Paid (Ex Special Dividend) $2.7B $3.1B $3.2B $3.2B $3.2B
Special Dividend Paid
Long-Term Debt Issued $3.9B $6.4B $1.6B $800M --
Long-Term Debt Repaid -$2.6B -$2.1B -$2.3B -$2.2B --
Repurchase of Common Stock $6.6B $6.9B $1.5B $831M $3.4B
Other Financing Activities -$40M -$179M $136M -$2M --
Cash From Financing -$8B -$6.1B -$5.2B -$5.5B -$6.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.4B $46M -$503M $176M -$127M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.5B $5.9B $4.8B $5.5B $6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $4.8B $5.4B $4.7B $5B $5.3B
Depreciation & Amoritzation $1.7B $1.7B $1.7B $1.8B $1.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$174M -$330M -$38M $37M -$27M
Change in Inventories -$26M -$173M -$29M -$32M -$13M
Cash From Operations $6.5B $7.1B $6B $6.7B $7.1B
 
Capital Expenditures $1.9B $2.7B $2.6B $2.5B $2.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.8B -$2.6B -$2.7B -$2.4B -$2.8B
 
Dividends Paid (Ex Special Dividend) $2B $2.4B $2.4B $2.4B $2.4B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.9B $6.1B $1.6B $800M $2B
Long-Term Debt Repaid -$1.4B -$2.2B -$2.2B -$2.2B -$409M
Repurchase of Common Stock $5.8B $5.5B $705M $831M $2.7B
Other Financing Activities -$36M -$246M $125M $279M $43M
Cash From Financing -$5.3B -$4.2B -$3.5B -$4.4B -$4.5B
 
Beginning Cash (CF) $3.6B $3B $2.7B $3B $3.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$580M $301M -$206M -$117M -$198M
Ending Cash (CF) $3B $3.3B $2.5B $2.9B $3.1B
 
Levered Free Cash Flow $4.6B $4.4B $3.4B $4.2B $4.3B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 4.05% over the past day.

Buy
52
ABVX alert for Dec 23

Abivax SA [ABVX] is up 0.41% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock